Urine benzodiazepine screening using Roche Online® KIMS immunoassay with β-glucuronidase hydrolysis and confirmation by gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 29, Issue 3, 2005, Pages 193-200

  Klette, Kevin L ^a   Wiegand, Russell F ^b   Horn, Carl K ^b   Stout, Peter R ^c   Magluilo Jr , Joseph ^d  

^a Navy Drug Screening Laboratory   (United States)

^b Navy Drug Screening Laboratory   (United States)

^c Aegis Sciences Corporation   (United States)

^d AFIP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; 7 AMINOFLUNITRAZEPAM; ALPHA HYDROXYALPRAZOLAM; ALPHA HYDROXYMIDAZOLAM; ALPHA HYDROXYTRIAZOLAM; ALPRAZOLAM; BENZODIAZEPINE; BETA GLUCURONIDASE; BROMAZEPAM; CLOBAZAM; CLONAZEPAM; CLORAZEPATE; DEALKYLFLURAZEPAM; DIAZEPAM; FLURAZEPAM; LORAZEPAM; MIDAZOLAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; PRAZEPAM; TEMAZEPAM; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; AUTOANALYZER; CALIBRATION; CROSS REACTION; DEVICE; DRUG SCREENING; DRUG URINE LEVEL; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOASSAY; IMMUNOCHEMISTRY; KINETIC INTERACTION OF MICROPARTICLES IN SOLUTION; MOLECULAR INTERACTION; ONLINE SYSTEM; SAMPLING;

EID: 17144420445     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.3.193     Document Type: Article

References (27)

1. K. Farrell. Benzodiazepines in the treatment of children with epilepsy. Epilepsia 27: 45-51 (1986).
2. T.R. Browne. Therapy of status epilepticus. Compr. Ther. 8:28-36 (1982).
3. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed., J.G. Hardman, L.E. Limbird, and A.G. Gilman, Eds. McGraw-Hill, New York, NY, 2001.
4. Research monograph series 73. National Institute on Drug Abuse. Benzodiazepines, 1986, p 111.
5. D.J. Garretty, K. Wolff, A.W.M. Hay, and D. Raistrick. Benzodiazepine misuse by drug addicts. Ann. Clin. Biochem. 34: 68-73 (1997).
6. L.P. Longo. Non-benzodiazepine pharmacotherapy of anxiety and panic in substance abusing patients. Psychiatr. Ann. 28: 142-153 (1998).
7. M. Linnoila. Drug interaction on psychomotor skills related to driving: hypnotics and alcohol. Ann. Med. Exp. Biol. Fenn. 51: 118-124 (1973).
8. M. Linnoila. Effects of diazepam, chlordiazepoxide, thioridazine, haloperidole, flupenthixole and alcohol on psychomotor skills related to driving. Ann. Med. Exp. Biol. Fenn. 51: 125-132 (1973).
9. M. Linnoila and S. Hakkinen. Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving. Clin. Pharmacol. Ther. 15: 368-374 (1974).
10. M. Linnoila and M.J. Mattila. Drug interaction on psychomotor skills related to driving: diazepam and alcohol. Eur. J. Clin. Pharmacol. 5: 186-194 (1973).
11. M. Linnoila, I. Saario, and M. Maki. Effect of treatment with diazepam or lithium and alcohol on psychomotor skills related to driving. Eur. J. Clin. Pharmacol. 7: 337-342 (1974).
12. M. Linnoila, I. Saario, J. Olkoniemi, R. Liljequist, J.J. Mimberg, and M. Maki. Effect of two weeks' treatment with chlordiazepoxide or flupenthixole, alone or in combination with alcohol, on psychomotor skills related to driving. Arzneimittelforschung 25: 1088-1092 (1975).
13. F. Barbone, A.D. McMahon, P.G. Davey, A.D. Morris, I.C. Reid, D.G. McDevitt, and T.M. MacDonald. Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1336 (1998).
14. B. Hemmelgarn, S. Suissa, A. Huang, J.F. Boivin, and G. Pinard, Benzodiazepine use and the risk of motor vehicle crash in the elderly. J. Am. Med. Assoc. 278: 27-31 (1997).
15. L.P. Raymond, B.W. Steele, and H.C. Walls. Benzodiazepines in Miami-Dade County, Florida driving under the influence (DUI) cases (1995-1998) with emphasis on Rohypnol®: confirmation, patterns of use, psychomotor impairment, and results of Florida legislation. J. Anal. Toxicol. 23: 490-499 (1999).
16. A. Boussairi, J.P. Dupeyron, B. Hernandez, D. Delaitre, L. Beugnet, P. Espinoza, and O. Diamant-Berger. Urine benzodiazepines screening of involuntary drugged and robbed or raped patients. J. Toxicol. Clin. Toxicol. 34: 721-724 (1996).
17. J.E. Ray, D.K. Reilly, and R.O. Day. Drugs involved in self-poisoning: verification by toxicological analysis. Med. J. Aust. 144: 455-457 (1986).
18. T. Rygnestad, K. Aarstad, K. Gustafsson, and U. Jenssen. The clinical value of drug analysis in deliberate self-poisoning. Hum. Exp. Toxicol. 9: 221-230 (1990).
19. K. Michel, C. Knecht, I. Kohler, and M. Sturzenegger. Attempted suicide in the Bern region. Schweiz. Med. Wochenschr. 121: 1133-1139 (1991) (in German).
20. J.G. Harvey and M.S. Christian. Deliberate overdosage in a hospital catchment area: preliminary results of a 7-year old study. Br. J. Acc. Emerg. Med. 1: 24-25 (1986).
21. R.H. Adams. An accident and emergency department's view of self-poisoning: a retrospective study from the United Norwich Hospitals 1978-1982. Hum. Toxicol. 5: 5-10 (1986).
22. P.T. Mearrick and J.S. Chahl. Screening for benzodiazepines in urine after hydrolysis of glucuronide conjugates. Clin. Chem. 31: 153 (1985).
23. O. Beck, P. Lafolie, G. Odelius, and L. Boreus. Immunological screening of benzodiazepines in urine: improved detection of oxazepam intake. Toxicol. Lett. 52: 7-14 (1990).
24. O. Beck, P. Lafolie, P. Hjemdahl, S. Borg, G. Odelius, and P. Wirbing. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis for urine: two techniques evaluated and modified for improved performance. Clin. Chem. 38: 271-275 (1992).
25. R. Meatherall. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required. J. Anal. Toxicol. 18: 385-390 (1994)
26. P. Simonsson, A. Liden, and S. Lindberg. Effect of β-glucuronidase on urinary benzodiazepine concentration determined by fluorescence polarization immunoassay. Clin. Chem. 41: 920-923 (1995).
27. R. Meatherall. Optimal enzymatic hydrolysis of urinary benzodiazepine conjugates. J. Anal. Toxicol. 18: 382-384 (1994).